Case File №
#VI-2026-0529
Hebei Rimao Technology
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
41 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | C Okay | 17 | 7.4 | 4.1 | 9.8 | 11 Aug 2025 |
| Tirzepatide | D Poor | 15 | 6.3 | 3.4 | 8.0 | 30 Sep 2025 |
| 1-Benzyl-4-piperidone CAS 3612-20-2 | X N/A | 3 | 7.4 | 6.8 | 8.3 | 24 May 2026 |
| 4-Anilinopiperidine CAS 99918-43-1 | X N/A | 2 | 7.3 | 6.0 | 8.6 | 19 Jan 2026 |
| Adamax | X N/A | 3 | 8.3 | 6.6 | 10.0 | 17 May 2026 |
| Andarine S4 | X N/A | 3 | 7.2 | 6.0 | 8.4 | 24 May 2026 |
| Boldenone Cypionate | X N/A | 3 | 7.3 | 6.6 | 8.8 | 17 May 2026 |
| Botulinum toxin | X N/A | 1 | 4.8 | 4.8 | 4.8 | 3 Jun 2025 |
| Crystagen | X N/A | 3 | 7.7 | 7.2 | 8.2 | 17 May 2026 |
| Dianabol Oil | X N/A | 3 | 7.3 | 6.7 | 7.7 | 17 May 2026 |
| Epithalon | X N/A | 3 | 7.8 | 6.6 | 10.0 | 26 Jan 2026 |
| EPO | X N/A | 1 | 7.0 | 7.0 | 7.0 | 13 Feb 2025 |
| Equipoise (Boldenone Undecylenate) | X N/A | 1 | 6.3 | 6.3 | 6.3 | 20 Jun 2025 |
| GLOW GHK-CU 35mg+TB500 10mg+BPC157 5mg | X N/A | 3 | 8.3 | 5.7 | 10.0 | 24 May 2026 |
| HGH Fragment 176-191 | X N/A | 3 | 6.7 | 4.5 | 9.6 | 19 Jan 2026 |
| HMG | X N/A | 3 | 6.3 | 5.3 | 6.9 | 20 May 2026 |
| IGF-1 LR3 | X N/A | 3 | 6.0 | 4.8 | 8.1 | 26 Jan 2026 |
| KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | X N/A | 1 | 6.2 | 6.2 | 6.2 | 3 Jun 2025 |
| LGD-4033 (Ligandrol) | X N/A | 1 | 6.9 | 6.9 | 6.9 | 13 Feb 2025 |
| Lipo-B 216mg | X N/A | 2 | 5.8 | 5.2 | 6.3 | 24 May 2026 |
| Methylstenbolone | X N/A | 2 | 5.6 | 3.2 | 7.9 | 21 May 2026 |
| MGF | X N/A | 2 | 7.7 | 5.4 | 10.0 | 21 May 2026 |
| NandroMix 300 | X N/A | 3 | 7.7 | 6.4 | 8.6 | 24 May 2026 |
| Oxytocin Acetate | X N/A | 3 | 7.2 | 5.4 | 8.2 | 23 May 2026 |
| P21 | X N/A | 2 | 7.0 | 4.4 | 9.6 | 24 May 2026 |
| PE 22-28 | X N/A | 1 | 5.5 | 5.5 | 5.5 | 25 Apr 2025 |
| PEG MGF | X N/A | 3 | 6.6 | 4.8 | 8.2 | 25 May 2026 |
| Primobolan Oral (Methenolone Acetate) | X N/A | 2 | 8.0 | 6.6 | 9.4 | 21 May 2026 |
| Retatrutide 30mg Pen Kit | X N/A | 2 | 4.9 | 3.8 | 6.1 | 25 May 2026 |
| RIPEX 225 (TRA/Mast P/Test P) | X N/A | 1 | 5.6 | 5.6 | 5.6 | 7 May 2025 |
| Romosozumab | X N/A | 2 | 8.9 | 8.4 | 9.5 | 21 May 2026 |
| S-23 Raw | X N/A | 1 | 6.6 | 6.6 | 6.6 | 16 Mar 2025 |
| Selank | X N/A | 1 | 5.9 | 5.9 | 5.9 | 13 Jun 2025 |
| Semaglutide Oral | X N/A | 1 | 5.4 | 5.4 | 5.4 | 9 Jun 2025 |
| Semax | X N/A | 2 | 5.8 | 5.1 | 6.4 | 21 May 2026 |
| Tamoxifen (Nolvadex) Raw | X N/A | 3 | 7.6 | 6.9 | 8.2 | 21 May 2026 |
| Test Enanthate | X N/A | 2 | 6.4 | 5.8 | 7.1 | 21 May 2026 |
| Testosterone Phenylpropionate Raw | X N/A | 2 | 5.5 | 5.4 | 5.6 | 23 May 2026 |
| Turinabol | X N/A | 2 | 9.4 | 8.9 | 10.0 | 24 May 2026 |
| Vitamin B12 10mg/ml | X N/A | 3 | 6.3 | 5.3 | 7.8 | 23 May 2026 |
| Winstrol (Stanozolol) | X N/A | 2 | 7.5 | 6.6 | 8.3 | 24 May 2026 |
Exhibit II
Evidence Log
91 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | Retatrutide 30mg Pen Kit | 4.3 C | 20mg | 17.2mg | -14.1% | 99.59% | w0ucae | Lab A | Community |
| 25 May 2026 | Semax | 5.5 B | 10mg | 8.5mg | -14.8% | 96.21% | gcto7w | Lab E | Public |
| 25 May 2026 | Winstrol (Stanozolol) | 6.2 A | 25mg | 23.2mg | -7.0% | 96.94% | z3syr1 | Lab C | Community |
| 24 May 2026 | Testosterone Phenylpropionate Raw | 4.0 C | 500g | 457.5g | -8.5% | 97.44% | vvzbst | Lab C | Public |
| 24 May 2026 | Andarine S4 | 6.9 A | 100mg | 104.0mg | +4.0% | 98.64% | i52d4a | Lab D | Community |
| 24 May 2026 | HMG | 6.7 A | 20mg | 24.6mg | +23.0% | 99.09% | b903ox | Lab B | Public |
| 24 May 2026 | RIPEX 225 (TRA/Mast P/Test P) | 5.0 B | 200mg/ml | 188.5mg/ml | -5.8% | 97.04% | ythi1f | Lab E | Community |
| 24 May 2026 | Romosozumab | 8.5 A | 20mg | 17.3mg | -13.6% | 97.96% | 3s7rav | Lab D | Community |
| 24 May 2026 | Tamoxifen (Nolvadex) Raw | 9.3 A | 100g | 91.6g | -8.4% | 95.14% | 4y00og | Lab A | Community |
| 24 May 2026 | Crystagen | 8.0 A | 2mg | 2.3mg | +15.7% | 98.24% | 15wykg | Lab B | Public |
| 24 May 2026 | Primobolan Oral (Methenolone Acetate) | 7.7 A | 10mg | 9.8mg | -2.3% | 99.00% | 77nukt | Lab A | Public |
| 24 May 2026 | Vitamin B12 10mg/ml | 4.5 C | 100mg/ml | 85.2mg/ml | -14.8% | 95.48% | u2jisx | Lab B | Public |
| 24 May 2026 | Retatrutide | 9.3 A | 20mg | 20.3mg | +1.5% | 99.60% | 333 | Lab G | Public |
| 24 May 2026 | Retatrutide | 9.5 A | 20mg | 20.3mg | +1.5% | 99.70% | 333 | Lab G | Public |
| 24 May 2026 | Retatrutide | 9.5 A | 20mg | 19.2mg | -4.0% | 99.70% | 333 | Lab G | Public |
| 24 May 2026 | Retatrutide | 9.5 A | 20mg | 19mg | -5.0% | 99.70% | 017 | Lab G | Public |
| 24 May 2026 | MGF | 6.1 A | 15mg | 14.2mg | -5.0% | 97.16% | 7cfylf | Lab C | Public |
| 24 May 2026 | P21 | 6.8 A | 50mg | 44.6mg | -10.9% | 95.85% | usarkx | Lab F | Public |
| 23 May 2026 | Tirzepatide | 3.4 E | 10mg | 11mg | +10.0% | 92.26% | (no batch ID) | Lab E | Public |
| 23 May 2026 | Tirzepatide | 6.5 B | 30mg | 11.2mg | -62.7% | 99.90% | 1/1/2026 | Lab E | Public |
| 23 May 2026 | Adamax | 8.4 A | 2mg | 2.3mg | +16.6% | 97.43% | yejxwe | Lab B | Public |
| 23 May 2026 | Turinabol | 7.5 A | 10mg | 11.4mg | +13.7% | 95.26% | zrbjmq | Lab G | Public |
| 21 May 2026 | Tirzepatide | 5.3 C | 30mg | 35mg | +16.7% | 99.86% | (no batch ID) | Lab E | Public |
| 21 May 2026 | 4-Anilinopiperidine CAS 99918-43-1 | 7.9 A | 500g | 536.0g | +7.2% | 97.38% | j5oxre | Lab B | Public |
| 21 May 2026 | GLOW GHK-CU 35mg+TB500 10mg+BPC157 5mg | 8.8 A | 2mg | 2.5mg | +23.3% | 97.78% | mcw078 | Lab D | Community |
| 21 May 2026 | Testosterone Phenylpropionate Raw | 6.9 A | 100g | 101.6g | +1.6% | 99.60% | 4m7ghy | Lab B | Public |
| 21 May 2026 | Adamax | 6.0 A | 20mg | 23.0mg | +15.1% | 97.56% | 93db05 | Lab F | Public |
| 21 May 2026 | HGH Fragment 176-191 | 5.3 B | 5mg | 6.0mg | +19.1% | 99.87% | x6fner | Lab F | Community |
| 21 May 2026 | Romosozumab | 10.0 A | 2mg | 2.4mg | +21.6% | 99.23% | 1odmgv | Lab F | Public |
| 20 May 2026 | Equipoise (Boldenone Undecylenate) | 6.3 A | 300mg/ml | 307.3mg/ml | +2.4% | 95.84% | 3l1lmv | Lab D | Public |
| 20 May 2026 | Semax | 5.8 B | 2mg | 2.3mg | +13.7% | 97.07% | 4f3aqa | Lab F | Public |
| 19 May 2026 | Dianabol Oil | 6.3 A | 200mg/ml | 191.8mg/ml | -4.1% | 98.23% | kd7t2h | Lab C | Community |
| 19 May 2026 | Test Enanthate | 6.8 A | 250mg/ml | 303.3mg/ml | +21.3% | 97.89% | 9d3rpt | Lab C | Community |
| 17 May 2026 | 1-Benzyl-4-piperidone CAS 3612-20-2 | 8.2 A | 1g | 0.9g | -10.4% | 97.26% | 9zluxt | Lab E | Public |
| 17 May 2026 | Boldenone Cypionate | 7.4 A | 100mg/ml | 121.7mg/ml | +21.7% | 96.82% | acwpur | Lab C | Public |
| 17 May 2026 | PE 22-28 | 5.5 B | 15mg | 13.8mg | -7.9% | 99.67% | nz7b4v | Lab F | Public |
| 17 May 2026 | Tamoxifen (Nolvadex) Raw | 8.6 A | 100g | 104.6g | +4.6% | 96.57% | wgioyt | Lab C | Public |
| 17 May 2026 | Vitamin B12 10mg/ml | 7.8 A | 300mg/ml | 285.3mg/ml | -4.9% | 95.49% | e1lxhp | Lab D | Community |
| 29 Jan 2026 | Botulinum toxin | 4.6 C | 30mg | 27.6mg | -8.1% | 98.87% | tfzfdq | Lab A | Public |
| 29 Jan 2026 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 6.0 A | 15mg | 18.5mg | +23.2% | 98.27% | a840qo | Lab G | Community |
| 29 Jan 2026 | Selank | 6.1 A | 5mg | 4.6mg | -7.5% | 98.60% | atl6vq | Lab A | Community |
| 29 Jan 2026 | Tamoxifen (Nolvadex) Raw | 7.1 A | 5g | 5.9g | +17.2% | 97.63% | 9cfcon | Lab E | Community |
| 26 Jan 2026 | 4-Anilinopiperidine CAS 99918-43-1 | 7.9 A | 500g | 493.3g | -1.3% | 95.49% | d3aspn | Lab B | Public |
| 26 Jan 2026 | Andarine S4 | 6.7 A | 25mg | 27.3mg | +9.4% | 98.53% | 0vtkd7 | Lab F | Public |
| 26 Jan 2026 | Boldenone Cypionate | 7.7 A | 250mg/ml | 244.3mg/ml | -2.3% | 95.81% | 95y7xe | Lab B | Public |
| 26 Jan 2026 | Epithalon | 7.6 A | 2mg | 2.1mg | +6.9% | 99.78% | 6oqodm | Lab D | Community |
| 26 Jan 2026 | IGF-1 LR3 | 5.4 B | 2mg | 2.5mg | +23.2% | 96.04% | 8f6a52 | Lab F | Community |
| 26 Jan 2026 | Methylstenbolone | 4.0 C | 100mg | 115.3mg | +15.3% | 98.87% | 3k2igt | Lab E | Public |
| 19 Jan 2026 | Dianabol Oil | 7.3 A | 300mg/ml | 342.4mg/ml | +14.1% | 95.34% | sytaso | Lab B | Public |
| 19 Jan 2026 | EPO | 8.1 A | 10mg | 12.5mg | +25.0% | 98.04% | pxv0th | Lab G | Community |
| 19 Jan 2026 | Methylstenbolone | 5.4 B | 25mg | 26.3mg | +5.1% | 99.84% | h6fy3v | Lab F | Community |
| 19 Jan 2026 | Oxytocin Acetate | 7.0 A | 2mg | 2.1mg | +5.4% | 96.50% | oekg5v | Lab E | Community |
| 19 Jan 2026 | PEG MGF | 8.2 A | 20mg | 22.4mg | +12.0% | 97.66% | ykewvt | Lab B | Public |
| 9 Jan 2026 | Adamax | 6.4 A | 50mg | 61.1mg | +22.1% | 97.43% | sy2uvv | Lab F | Community |
| 9 Jan 2026 | Crystagen | 8.8 A | 50mg | 61.2mg | +22.4% | 95.71% | 8z2ii6 | Lab C | Community |
| 7 Jan 2026 | Dianabol Oil | 4.7 C | 300mg/ml | 278.9mg/ml | -7.0% | 99.85% | x83ri2 | Lab B | Public |
| 7 Jan 2026 | GLOW GHK-CU 35mg+TB500 10mg+BPC157 5mg | 8.2 A | 20mg | 24.9mg | +24.5% | 98.01% | 94msre | Lab F | Public |
| 7 Jan 2026 | HGH Fragment 176-191 | 7.8 A | 15mg | 14.4mg | -4.0% | 95.27% | u5xzfr | Lab A | Public |
| 7 Jan 2026 | HMG | 5.5 B | 15mg | 15.2mg | +1.4% | 97.55% | sch0qy | Lab C | Community |
| 7 Jan 2026 | LGD-4033 (Ligandrol) | 6.9 A | 20mg | 22.8mg | +14.1% | 97.97% | vuvjou | Lab A | Public |
| 7 Jan 2026 | Retatrutide 30mg Pen Kit | 6.3 A | 20mg | 22.6mg | +12.9% | 99.73% | 71i2ns | Lab E | Public |
| 6 Jan 2026 | Boldenone Cypionate | 9.7 A | 200mg/ml | 205.9mg/ml | +3.0% | 95.97% | dex7fz | Lab E | Public |
| 6 Jan 2026 | Epithalon | 8.5 A | 15mg | 18.5mg | +23.5% | 97.18% | mpp5dw | Lab F | Public |
| 6 Jan 2026 | GLOW GHK-CU 35mg+TB500 10mg+BPC157 5mg | 8.4 A | 15mg | 15.9mg | +5.8% | 96.38% | dsf3or | Lab E | Public |
| 6 Jan 2026 | IGF-1 LR3 | 5.6 B | 15mg | 18.7mg | +24.7% | 95.79% | tsrbk1 | Lab D | Community |
| 29 Dec 2025 | Lipo-B 216mg | 4.0 C | 100mg/ml | 107.3mg/ml | +7.3% | 99.17% | 033myw | Lab F | Public |
| 29 Dec 2025 | PEG MGF | 4.5 C | 30mg | 36.5mg | +21.5% | 96.01% | 01jyy8 | Lab C | Community |
| 29 Dec 2025 | Winstrol (Stanozolol) | 7.1 A | 25mg | 30.0mg | +20.1% | 96.71% | lluhqx | Lab D | Public |
| 23 Nov 2025 | Epithalon | 8.9 A | 10mg | 9.7mg | -3.3% | 95.06% | ws4mmv | Lab F | Community |
| 23 Nov 2025 | HMG | 5.9 B | 5mg | 4.6mg | -8.9% | 95.68% | t70ya7 | Lab C | Public |
| 23 Nov 2025 | Lipo-B 216mg | 6.6 A | 300mg/ml | 270.3mg/ml | -9.9% | 97.60% | d5m9td | Lab E | Community |
| 23 Nov 2025 | Test Enanthate | 7.8 A | 300mg/ml | 303.9mg/ml | +1.3% | 98.62% | lwkmmd | Lab D | Public |
| 23 Nov 2025 | Vitamin B12 10mg/ml | 4.1 C | 200mg/ml | 207.4mg/ml | +3.7% | 97.64% | duoavt | Lab E | Public |
| 17 Nov 2025 | Oxytocin Acetate | 7.0 A | 20mg | 20.1mg | +0.4% | 97.87% | nlsugo | Lab D | Community |
| 14 Nov 2025 | S-23 Raw | 7.2 A | 100g | 107.0g | +7.0% | 97.95% | yccpot | Lab G | Public |
| 5 Nov 2025 | P21 | 6.6 A | 30mg | 35.6mg | +18.8% | 97.64% | 2mv81h | Lab B | Public |
| 4 Nov 2025 | 1-Benzyl-4-piperidone CAS 3612-20-2 | 7.2 A | 5g | 5.9g | +17.5% | 98.42% | cuv3d0 | Lab E | Public |
| 4 Nov 2025 | HGH Fragment 176-191 | 7.1 A | 5mg | 4.3mg | -13.6% | 97.75% | i8857v | Lab A | Community |
| 17 Oct 2025 | IGF-1 LR3 | 4.4 C | 2mg | 1.7mg | -13.1% | 95.97% | 2ig4ns | Lab C | Community |
| 17 Oct 2025 | MGF | 5.2 B | 15mg | 18.0mg | +20.0% | 99.60% | dcnitd | Lab E | Community |
| 17 Oct 2025 | NandroMix 300 | 8.7 A | 250mg/ml | 297.6mg/ml | +19.0% | 96.84% | 9vwmvx | Lab G | Public |
| 17 Oct 2025 | PEG MGF | 7.3 A | 15mg | 15.3mg | +1.8% | 99.37% | 38rrq1 | Lab A | Public |
| 9 Oct 2025 | Crystagen | 8.4 A | 5mg | 6.0mg | +19.1% | 97.77% | 4udsus | Lab A | Community |
| 9 Oct 2025 | NandroMix 300 | 8.5 A | 250mg/ml | 268.6mg/ml | +7.4% | 98.92% | a1pbv5 | Lab F | Public |
| 9 Oct 2025 | Oxytocin Acetate | 5.4 B | 5mg | 5.7mg | +13.7% | 97.80% | 1hel2o | Lab D | Public |
| 9 Oct 2025 | Turinabol | 9.0 A | 20mg | 18.3mg | -8.4% | 96.10% | gkvbcq | Lab B | Community |
| 3 Oct 2025 | 1-Benzyl-4-piperidone CAS 3612-20-2 | 4.2 C | 1g | 1.2g | +23.1% | 95.02% | btbw74 | Lab F | Community |
| 3 Oct 2025 | Andarine S4 | 5.6 B | 10mg | 8.8mg | -12.4% | 95.38% | r6kreo | Lab D | Community |
| 3 Oct 2025 | NandroMix 300 | 8.4 A | 250mg/ml | 302.0mg/ml | +20.8% | 98.43% | 5lwnxq | Lab B | Public |
| 3 Oct 2025 | Primobolan Oral (Methenolone Acetate) | 6.7 A | 20mg | 19.4mg | -2.8% | 97.89% | 420xkh | Lab G | Public |
| 3 Oct 2025 | Semaglutide Oral | 9.3 A | 25mg | 29.8mg | +19.1% | 96.68% | pdzmup | Lab E | Public |
— END OF EVIDENCE LOG —